MK-7602: a potent multi-stage dual-targeting antimalarial is a research paper published in EBioMedicine (2025). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Health and Medical Research Council
Grant: APP1176955
Human Frontier Science Program
Grant: LT0001/2022-L
NIAID NIH HHS
Grant: R01 AI173171
Wellcome Trust
Grant: 219658/Z/19/Z
Public Health Institute
Grant: Dd2-SJ557733
National Health and Medical Research Council
Grant: APP1194535
National Institute of Allergy and Infectious Diseases Division of Intramural Research
Grant: R61AI187100
Wellcome Trust
Grant: 109662/Z/15/Z
Wellcome Trust
Grant: GNT637406
NIAID NIH HHS
Grant: R01 AI175134
Wellcome Trust
Grant: 202749/Z/16/Z
Public Health Institute
Grant: Dd2-NITD609
Wellcome Trust
Grant: GNT1173049
Wellcome Trust
Grant: GNT1176955
State Government of Victoria
Wellcome Trust
Australian Red Cross Lifeblood
Department of Health Victoria
National Institute of Allergy and Infectious Diseases
National Institutes of Health
MeSH Terms
Keywords